mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.2 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |